Work

Abstract 5449: Preclinical development of SCR-A003, a novel topoisomerase I inhibitor-based antibody-drug conjugate (ADC) targeting LIV-1 for solid cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5449

Authors: Yayuan Fu, Changyan Chen, Xiaohua Yan, Zhiyong Yu, Zhuangzhi Zhao, Jingli Liao, Zhenyun Tian, Renhong Tang

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409633717

Cites:

Cited by:

Related to: 10